Sign up for our Oncology Central weekly news round-up

Local ablative therapies as key treatment options for selected metastatic renal cell carcinoma: an interview with Sara Elena Rebuzzi

Written by Sara Elena Rebuzzi (University of Genova, Italy)

renal cell carcinoma

Oncology Central recently spoke with Sara Elena Rebuzzi (University of Genova, Italy) about the challenges of treating renal cell carcinoma and her recent research into metastatic renal cell carcinoma pretreated with pazopanib. Read the full interview below: Please could you introduce yourself, your research background and current research interests. I am a medical doctor and I am attending my last year of medical oncology residency at the University of Genova. I am currently working in the Medical Oncology Unit of Prof Alberto Sobrero at IRCCS Ospedale Policlinico San Martino of Genova (Italy), in collaboration with Dr Giuseppe Fornarini, who is...

To view this content, please register now for access

It's completely free